ReWalk Robotics

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

Ekso Bionics Hlds

Science fiction collides with reality, as exoskeletons become a real-world device with a number of applications. The post 2 Science-Fiction Stocks to Play This Emerging Megatrend appeared first on InvestorPlace.

2 Science-Fiction Stocks to Play This Emerging Megatrend

Amazon

Brooks Automation

iRobot

Teradyne

Here we focus on five stocks with strong potential to reap the benefits from the booming robotics market worldwide.

Robotics Continues to Gain Strong Momentum: 5 Stocks in Focus

FANUC Corp

Rockwell Automation

Stryker

Trimble

Robotics stocks are poised to grow in 2021, calling for investment in Trimble (TRMB), Rockwell Automation (ROK), ReWalk Robotics (RWLK), Fanuc Corp (FANUY) and Stryker (SYK).

Robots Will Rule 2021: 5 Stocks Poised to Benefit

ReWalk shares have recently moved up in spite of new equity issuance. The third quarter saw reduced revenues due to Covid-19 but still managed to use less cash in operations, which is trending strongly towards a break-even point in 2023.

ReWalk Robotics: A Turbulent Journey In The Right Direction

MARLBOROUGH, Mass., Dec. 21, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced it has donated one of its ReStore Exo-suits to Brooks Rehabilitation,...

ReWalk Robotics Donates ReStore Exo-Suit to Brooks Rehabilitation to Support Stroke Survivors

ReWalk Robotics (RWLK) news for Thursday concerning a contract in Germany for its exoskeletons has RWLK stock soaring higher. The post ReWalk Robotics News: Why RWLK Stock Is Powering Higher Thursday appeared first on InvestorPlace.

ReWalk Robotics News: Why RWLK Stock Is Powering Higher Thursday

Supply contract is the Company's first with a private health insurer in Germany

Leading German Private Health Insurer Enters Contract to Provide ReWalk Exoskeletons to Individuals with Spinal Cord Injuries

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Dec. 08, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced the closing of its previously announced private placement of 5,579,776 ordinary shares and warrants to purchase up to 4,184,832 ordinary shares, at a purchase price of $1.43375 per share and associated warrant, that was priced “at-the-market” under Nasdaq Rules and resulted in gross proceeds of approximately $8.0 million before the deduction of placement agent fees and expenses and estimated offering expenses payable by the Company. The warrants have a term of five and one-half years, are exercisable immediately and have an exercise price of $1.34 per ordinary share.

ReWalk Robotics Announces Closing of $8.0 Million Private Placement Priced At-the-Market

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise $8.0 million through the issuance of 5,579,776 its ordinary shares and warrants to purchase up to 4,184,832 ordinary shares, at a purchase price of $1.43375 per share and associated warrant, in a private placement priced “at-the-market” under Nasdaq Rules. The warrants will have a term of five and one-half years, be exercisable immediately following the issuance date and have an exercise price of $1.34 per ordinary share.

ReWalk Robotics Announces $8.0 Million Private Placement Priced At-the-Market

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinski on Q3 2020 Results - Earnings Call Transcript

MARLBOROUGH, Mass. and BERLIN, Germany and YOKNEAM ILIT, Israel, Nov. 10, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2020.

ReWalk Robotics Reports Third Quarter 2020 Financial Results

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement will present a fireside chat at the H.C.WAINWRIGHT virtual conference at 01:30 PM EST on Thursday November 12, 2020.

ReWalk Robotics to Present at the H.C. WAINWRIGHT 6th Annual Israel Virtual Conference on November 12th, 2020

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Nov. 06, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2020 financial results on Tuesday, November 10, 2020, before the U.S. financial markets open.   

ReWalk Robotics to Report Third Quarter 2020 Financial Results on November 10, 2020

Ms. Richner is an experienced public health policy professional with over 30 years of experience in Medical Devices, Reimbursement Strategy and Health Care Policy

ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept.  10, 2020  (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon, Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement, will present at the H.C. WAINWRIGHT virtual conference at 11:00 EST on Tuesday, September 15, 2020.

ReWalk Robotics to Present at the H.C. WAINWRIGHT 22nd Annual Global Investment Virtual Conference on September 15th, 2020

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug.  27, 2020  (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the U.S. Court of Appeals for the First Circuit dismissed a class action lawsuit filed in 2017 against ReWalk.

U.S. Court of Appeals Dismisses Securities Lawsuit Against ReWalk Robotics

ReWalk Robotics: Now Or Never Time

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinski on Q2 2020 Results - Earnings Call Transcript

Shares of ReWalk Robotics (NASDAQ:RWLK) moved higher by 1.7% in pre-market trading after the company reported Q2 results.

Recap: ReWalk Robotics Q2 Earnings

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug.  07, 2020  (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2020 financial results on Wednesday, August 12, 2020, before the U.S. financial markets open.

ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020

ReWalk (RWLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ReWalk Robotics (RWLK) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

MARLBOROUGH, Mass., July 15, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the Centers for Medicare and Medicaid Services ("CMS") issued...

Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July  06, 2020  (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 4,938,278 of the Company’s ordinary shares, at a purchase price of $1.8225 per ordinary share, priced at-the-market under Nasdaq Rules. ReWalk also issued unregistered warrants to purchase up to an aggregate amount of 2,469,139 ordinary shares. 

ReWalk Robotics Announces Closing of $9.0 Million Registered Direct Offering  Priced At-the-Market Under Nasdaq Rules

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July  01, 2020  (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with several institutional investors providing for the issuance of approximately 4,938,278 of the Company’s ordinary shares, at a purchase price of $1.8225, in a registered direct offering priced at-the-market under Nasdaq Rules. ReWalk has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate amount of 2,469,139 ordinary shares. The offering is expected to close on or about July 6, 2020, subject to satisfaction of customary closing conditions.

ReWalk Robotics Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Over the past three months, shares of ReWalk Robotics Inc. (NASDAQ: RWLK) increased by 267.93%.

News for ReWalk Robotics Stock (RWLK)